File Download
There are no files associated with this item.
Supplementary
-
Citations:
- Appears in Collections:
Article: Systemic Lupus Erythematosus And Immunodeficiency
Title | Systemic Lupus Erythematosus And Immunodeficiency |
---|---|
Authors | |
Issue Date | 2021 |
Publisher | De Gruyter Open Access. |
Citation | Rheumatology And Immunology Research, 2021, v. 2, p. 131-138 How to Cite? |
Abstract | Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease caused by a combination of genetic, epigenetic, and environmental factors. Recent advances in genetic analysis coupled with better understanding of different immune regulatory and signaling pathways have revealed the complex relationship between autoimmunity, including SLE, and immunodeficiency. Furthermore, the expanding therapeutic armamentarium has led to the increasing awareness of secondary immunodeficiency in these patients. This article serves to update the current understanding of SLE and immunodeficiency by discussing the shared genetic factors and immunobiology. We also summarize the effects of immunosuppressive therapies with a focus on secondary antibody deficiency (SAD) after B-cell targeted therapies. |
Persistent Identifier | http://hdl.handle.net/10722/319245 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chan, CWS | - |
dc.contributor.author | Lau, WCS | - |
dc.date.accessioned | 2022-10-14T05:09:47Z | - |
dc.date.available | 2022-10-14T05:09:47Z | - |
dc.date.issued | 2021 | - |
dc.identifier.citation | Rheumatology And Immunology Research, 2021, v. 2, p. 131-138 | - |
dc.identifier.uri | http://hdl.handle.net/10722/319245 | - |
dc.description.abstract | Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease caused by a combination of genetic, epigenetic, and environmental factors. Recent advances in genetic analysis coupled with better understanding of different immune regulatory and signaling pathways have revealed the complex relationship between autoimmunity, including SLE, and immunodeficiency. Furthermore, the expanding therapeutic armamentarium has led to the increasing awareness of secondary immunodeficiency in these patients. This article serves to update the current understanding of SLE and immunodeficiency by discussing the shared genetic factors and immunobiology. We also summarize the effects of immunosuppressive therapies with a focus on secondary antibody deficiency (SAD) after B-cell targeted therapies. | - |
dc.language | eng | - |
dc.publisher | De Gruyter Open Access. | - |
dc.relation.ispartof | Rheumatology And Immunology Research | - |
dc.title | Systemic Lupus Erythematosus And Immunodeficiency | - |
dc.type | Article | - |
dc.identifier.email | Chan, CWS: scwchan@hku.hk | - |
dc.identifier.email | Lau, WCS: cslau@hku.hk | - |
dc.identifier.authority | Chan, CWS=rp02942 | - |
dc.identifier.authority | Lau, WCS=rp01348 | - |
dc.identifier.doi | 10.2478/rir-2021-0019 | - |
dc.identifier.hkuros | 338791 | - |
dc.identifier.volume | 2 | - |
dc.identifier.spage | 131 | - |
dc.identifier.epage | 138 | - |